About a dozen advocacy groups and unions, including Public Citizen and the American Federation of Teachers, wrote the Federal Trade Commission on Thursday urging it to consider blocking drugmaker AbbVie Inc’s planned $63 billion purchase of Botox maker Allergan Plc . The combination of two of the world’s biggest pharmaceutical companies, which was announced in June, would feature a portfolio that includes the world’s top-selling medicine – AbbVie’s rheumatoid arthritis drug Humira – as well as its cancer drugs and Allergan’s blockbuster wrinkle treatment, Botox, and big-selling dry eye drug Restasis.

source https://finance.yahoo.com/news/consumer-groups-unions-urge-caution-222256384.html?.tsrc=rss